January 8th, 2009
Rehovot, Israel – January 8th, 2009 – Evogene (TASE:EVGN) announced today plans to invest approximately $2 million (8 million Israeli shekels) to expand its research and administrative facilities during 2009 to support its rapidly expanding R&D programs and collaboration activities.
This investment consists of an estimated $1.2 million (4.5 million Israeli shekels) for construction of state-of-the-art greenhouses for model and target plant growth, and approximately $0.7 million (2.5 million Israeli shekels) related to the company's existing facilities in Rehovot, including expansion of its molecular biology labs, tissue culture rooms, computational infrastructure and offices.
print page |
